The global research pharmaceutical sector has deployed about PhP200 million worth of medicines, relief items and cash donations for the millions of victims of typhoon Yolanda (Haiyan) in the Philippines.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), representing the research-based pharmaceutical companies across the globe, said that an initial USD 4.3 million worth of medicines, vaccines, vitamins, medical supplies, relief items, and cash donations has been forwarded to various international aid organizations but that donations continue to be recorded. Among the organizations receiving this aid are the Red Cross, Save the Children, Direct Relief, and AmeriCares among others.
A member of the IFPMA, the Pharmaceutical and Healthcare Association of the Philippines (PHAP) will also turn over today a separate PhP14.2 million worth of medicines and vaccines to government partners and hospitals in Eastern Visayas.
PHAP, through the PHAPCares Foundation, will be in a one-week mission in typhoon-battered provinces in Leyte and Samar to hand over needed medicines and vaccines to the Office-Civil Defense Regional Risk Reduction and Management Council in Eastern Visayas and some hospitals in the region to augment government resources. The PHAPCares Foundation will also be traveling to other typhoon-ravaged provinces in MIMAROPA, and Western and Central Visayas.
“We are in close coordination with the government and our private partners in assessing the medicine requirements of the typhoon survivors. PHAP members and our global counterparts are fully supporting humanitarian efforts focusing on restoring the health of the victims especially the very vulnerable,” said PHAP executive director and PHAPCares CEO Teodoro B. Padilla.
PHAPCares Foundation managing director Dr. Edgar Posadas said that they will be transporting tetanus vaccines as well as essential medicines to Tacloban City today.
The World Health Organization (WHO) said that major trauma and injuries, the displacement of thousands of people, lack of access to food, water and sanitation, increased communicable diseases as well as vector-borne diseases and leptospirosis are among the health risks that it is closely monitoring with the Department of Health (DOH).
During the humanitarian mission, PHAPCares will also hand over relief packs donated by the PHAP and PHAPCares staff who decided to cancel their annual yearend gathering so that they may use the fund to donate to the victims.
PHAP is a non-stock and non-profit association which mission is to produce, enhance, and make accessible quality and safe medicines to enable Filipinos to achieve longer and healthier lives. PHAP also advocates for comprehensive health reform leading to universal healthcare and the ethical promotion of pharmaceutical products. It is a member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the World Self-Medication Industry (WSMI).
Through the PHAPCares Foundation, PHAP undertakes meaningful corporate social responsibility programs to help the poor, sick and victims of calamities.
For reference, please call the Pharmaceutical and Healthcare Association of the Philippines at telephone number 8141808 or 0917 8082132. You may also log on to www.phap.org.ph and www.phapcares.org.ph.